The study is to gather evidence of LFG316 efficacy in treatment of transplant associated microangiopathy (TAM) after hematopoetic precursor cell transplantation

Update Il y a 4 ans
Reference: EUCTR2014-004972-49

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the hematological response rate in patients with TAM receiving LFG316 compared to standard of care (SoC)


Inclusion criteria

  • Transplant associated microangiopathy (TAM)